Cardiovascular complications in children with chronic kidney disease

Nature Reviews Nephrology

Volumn 7, Issue 11, 2011, Pages 642-649

  Shroff, Rukshana ^a   Weaver Jr , Donald J ^b   Mitsnefes, Mark M ^c  

^a Nephrology Unit   (United Kingdom)

^b CAROLINAS MEDICAL CENTER   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIMIMETIC AGENT; CALCIUM ACETATE; SEVELAMER; VITAMIN D;

BLOOD PRESSURE; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL RESEARCH; DRUG BINDING; FITNESS; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MORPHOLOGICAL ADAPTATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM;

CARDIOVASCULAR DISEASES; CHILD; HUMANS; INCIDENCE; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; UREMIA;

EID: 80155214696     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2011.116     Document Type: Review

References (95)

1. McDonald, S. P. & Craig, J. C. for the Australian and New Zealand Paediatric Nephrology Association. Long-term survival of children with end-stage renal disease. N. Engl. J. Med. 350, 2654-2662 (2004).
2. Groothoff, J. W. et al. Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int. 61, 621-629 (2002).
3. Chavers, B. M., Li, S., Collins, A. J. & Herzog, C. A. Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int. 62, 648-653 (2002).
4. Parekh, R. S., Carroll, C. E., Wolfe, R. A. & Port, F. K. Cardiovascular mortality in children and young adults with end-stage kidney disease. J. Pediatr. 141, 191-197 (2002).
5. Mitsnefes, M. M. Cardiovascular complications of pediatric chronic kidney disease. Pediatr. Nephrol. 23, 27-39 (2008).
6. Wilson, A. C. & Mitsnefes, M. M. Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management. Am. J. Kidney Dis. 54, 345-360 (2009).
7. Hadstein, C. & Schaefer, F. Hypertension in children with chronic kidney disease: pathophysiology and management. Pediatr. Nephrol. 23, 363-371 (2008).
8. Silverstein, D. M. Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr. Nephrol. 24, 1445-1452 (2009).
9. Lilien, M. R. & Groothoff, J. W. Cardiovascular disease in children with CKD or ESRD. Nat. Rev. Nephrol. 5, 229-235 (2009).
10. Shroff, R., Quinlan, C. & Mitsnefes, M. M. Uraemic vasculopathy in children with chronic kidney disease: prevention or damage limitation? Pediatr. Nephrol. 26, 853-865 (2011).
11. Johnstone, L. M. et al. Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int. 50, 998-1006 (1996).
12. Mitsnefes, M. M. et al. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2 year follow-up study. J. Pediatr. 149, 671-675 (2006).
13. Glassock, R. J., Pecoits-Filho, R. & Barberato, S. H. Left ventricular mass in chronic kidney disease and ESRD. Clin. J. Am. Soc. Nephrol. 4 (Suppl. 1), S79-S91 (2009).
14. Mitsnefes, M. M. et al. Masked hypertension associates with left ventricular hypertrophy in children with CKD. J. Am. Soc. Nephrol. 21, 137-144 (2010).
15. Ulinski, T., Genty, J., Viau, C., Tillous-Borde, I. & Deschênes, G. Reduction of left ventricular hypertrophy in children undergoing hemodialysis. Pediatr. Nephrol. 21, 1171-1178 (2006).
16. Mitsnefes, M. M. et al. Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr. Nephrol. 14, 898-902 (2000).
17. Bullington, N., Kartal, J., Khoury, P. & Mitsnefes, M. M. Left ventricular hypertrophy in pediatric kidney transplant recipients: long-term follow-up study. Pediatr. Transplant. 10, 811-815 (2006).
18. Wilson, A. C. et al. High prevalence of the metabolic syndrome and associated left ventricular hypertrophy in pediatric renal transplant recipients. Pediatr. Transplant. 14, 52-60 (2010).
19. Sinha, M. D. et al. Blood pressure control and left ventricular mass in children with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 6, 543-551 (2011).
20. Chinali, M. et al. Reduced systolic myocardial function in children with chronic renal insufficiency. J. Am. Soc. Nephrol. 18, 593-598 (2007).
21. Mitsnefes, M. M. et al. Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism. J. Am. Soc. Nephrol. 16, 2796-2803 (2005).
22. Weaver, D. J. Jr, Kimball, T. R., Koury, P. R. & Mitsnefes, M. M. Cardiac output and associated left ventricular hypertrophy in pediatric chronic kidney disease. Pediatr. Nephrol. 24, 565-570 (2009).
23. Raimondi, F. et al. Inappropriate left ventricular mass in children and young adults with chronic renal insufficiency. Pediatr. Nephrol. 24, 2015-2022 (2009).
24. Weaver, D. J. Jr et al. Subclinical systolic dysfunction in pediatric patients with chronic kidney disease. J. Pediatr. 153, 565-569 (2008).
25. Mitsnefes, M. M. et al. Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation 107, 864-868 (2003).
26. Mese, T. et al. Contractility reserve in children undergoing dialysis by dobutamine stress echocardiography. Pediatr. Cardiol. 31, 937-943 (2010).
27. Hothi, D. K., Rees, L., Marek, J., Burton, J. & McIntyre, C. W. Pediatric myocardial stunning underscores the cardiac toxicity of conventional hemodialysis treatments. Clin. J. Am. Soc. Nephrol. 4, 790-797 (2009).
28. Mitsnefes, M. M. et al. Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int. 65, 1461-1466 (2004).
29. Weaver, D. J. Jr et al. Decreased maximal aerobic capacity in pediatric chronic kidney disease. J. Am. Soc. Nephrol. 19, 624-630 (2008).
30. Shroff, R. C. & Shanahan, C. M. The vascular biology of calcification. Semin. Dial. 20, 103-109 (2007).
31. Shroff, R. C. et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 118, 1748-1757 (2008).
32. Blacher, J. et al. Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int. 63, 1852-1860 (2003).
33. London, G. M. et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol. Dial. Transplant. 18, 1731-1740 (2003).
34. Civilibal, M. et al. Coronary artery calcifications in children with end-stage renal disease. Pediatr. Nephrol. 21, 1426-1433 (2006).
35. Goodman, W. G. et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N. Engl. J. Med. 342, 1478-1483 (2000).
36. Litwin, L. et al. Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J. Am. Soc. Nephrol. 16, 1494-1500 (2005).
37. Oh, J. et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106, 100-105 (2002).
38. Shroff, R. C. et al. Mineral metabolism and vascular damage in children on dialysis. J. Am. Soc. Nephrol. 18, 2996-3003 (2007).
39. Briese, S. et al. Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy. Nephrol. Dial. Transplant. 21, 1906-1914 (2006).
40. Civilibal, M. et al. Traditional and "new" cardiovascular risk markers and factors in pediatric dialysis patients. Pediatr. Nephrol. 22, 1021-1029 (2007).
41. Covic, A. et al. Increased arterial stiffness in children on haemodialysis. Nephrol. Dial. Transplant. 21, 729-735 (2006).
42. Srivaths, P. R., Silverstein, D. M., Leung, J., Krishnamurthy, R. & Goldstein, S. L. Malnutrition inflammation coronary calcification in pediatric patients receiving chronic hemodialysis. Hemodial. Int. 14, 263-269 (2010).
43. Shroff, R. et al. A bimodal association of vitamin D levels and vascular disease in children on dialysis. J. Am. Soc. Nephrol. 19, 1239-1246 (2008).
44. Zittermann, A., Schleithoff, S. S. & Koerfer, R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br. J. Nutr. 94, 483-492 (2005).
45. Ketteler, M. et al. Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia. Kidney Int. Suppl. 84, S84-S87 (2003).
46. Shroff, R. C. et al. The circulating calcification inhibitors, fetuin A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol. Dial. Transplant. 23, 3263-3271 (2008).
47. van Summeren, M. J. et al. Circulating calcification inhibitors and vascular properties in children after renal transplantation. Pediatr. Nephrol. 6, 985-993 (2008).
48. Shroff, R. C. et al. Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J. Am. Soc. Nephrol. 21, 103-112 (2010).
49. Johnson, K. L. Exercise in the end-stage renal disease population. J. Am. Soc. Nephrol. 18, 1845-1854 (2007).
50. Painter, P., Krasnoff, J. & Mathias, R. Exercise capacity and physical fitness in pediatric dialysis and kidney transplant patients. Pediatr. Nephrol. 22, 1030-1039 (2007).
51. Goldstein, S. L. et al. Health-related quality of life in pediatric patients with ESRD. Pediatr. Nephrol. 21, 846-850 (2006).
52. Gerson, A. C. et al. Health-related quality of life of children with mild to moderate chronic kidney disease. Pediatrics 125, e349-e357 (2010).
53. Booher, M. A. & Smith, B. W. Physiological effects of exercise on the cardiopulmonary system. Clin. Sports Med. 22, 1-21 (2003).
54. Pattaragarn, A., Warady, B. A. & Sabath, R. J. Exercise in pediatric patients with end-stage renal disease. Perit. Dial. Int. 24, 274-280 (2004).
55. Eijsermans, R. M., Creemers, D. G., Helders, P. J. & Schröder, C. H. Motor performance, exercise tolerance, and health-related quality of life in children on dialysis. Pediatr. Nephrol. 19, 1262-1266 (2004).
56. Tangeraas, T. et al. Cardiorespiratory fitness is a marker of cardiovascular health in renal transplanted children. Pediatr. Nephrol. 25, 2343-2350 (2010).
57. Narayan, P. et al. Association of hemoglobin delivery with left ventricular structure and function in hypertensive patients: losartan intervention for end point reduction in hypertension study. Hypertension 47, 868-873 (2006).
58. Goldstein, S. L. & Montgomery, L. R. A pilot study of twice-weekly exercise during hemodialysis in children. Pediatr. Nephrol. 24, 833-839 (2009).
59. van Bergen, M. et al. Exercise training in pediatric patients with end-stage renal disease. Pediatr. Nephrol. 24, 619-622 (2009).
60. ESCAPE Trial Group. Wühl, E. et al. Strict blood-pressure control and progression of renal failure in children. N. Engl. J. Med. 361, 1639-1650 (2009).
61. Fischbach, M., Dheu, C., Seuge, L., Menouer, S. & Terzic, J. In-center daily on-line hemodiafiltration: a 4 year experience in children. Clin. Nephrol. 69, 279-284 (2008).
62. Geary, D. F. et al. Home nocturnal hemodialysis in children. J. Pediatr. 147, 383-387 (2005).
63. Nesrallah, G., Sure, R., Moist, L., Kortas, C. & Lindsay, R. M. Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am. J. Kidney Dis. 42 (Suppl. 1), 13-17 (2003).
64. Fagugli, R. M. et al. Association between extracellular water, left ventricular mass and hypertension in haemodialysis patients. Nephrol. Dial. Transplant. 18, 2332-2338 (2003).
65. Han, C. T., Floras, J. S., Miller, J. A., Richardson, R. M. & Pierratos, A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int. 61, 2235-2239 (2002).
66. The FHN Trial Group. In-center hemodialysis six times per week versus three times per week. N. Engl. J. Med. 363, 2287-2300 (2010).
67. Rees, L. What parathyroid hormone levels should we aim for in children with stage 5 chronic kidney disease; what is the evidence? Pediatr. Nephrol. 23, 179-184 (2008).
68. KDOQI Work Group. KDOQI clinical practice guidelines for nutrition in children with CKD: 2008 update. Executive summary. Am. J. Kidney Dis. 53 (3 Suppl. 2), S11-S104 (2003).
69. Isakova, T. et al. Phosphorus binders and survival on hemodialysis. J. Am. Soc. Nephrol. 20, 388-396 (2009).
70. Rees, L. & Shroff, R. C. Phosphate binders in CKD: chalking out the differences. Pediatr. Nephrol. 25, 385-394 (2010).
71. Uhlig, K. et al. KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD). Am. J. Kidney Dis. 55, 773-799 (2010).
72. Pieper, A. K. et al. A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD. Am. J. Kidney Dis. 47, 625-635 (2006).
73. Civilibal, M. et al. Progression of coronary calcification in pediatric chronic kidney disease stage 5. Pediatr. Nephrol. 24, 555-563 (2009).
74. Suki, W. N. et al. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int. 72, 1130-1137 (2007).
75. Drüeke, T. B. Treatment of secondary hyperparathyroidism of dialysis patients with calcimimetics as a valuable addition to established therapeutic means. Pediatr. Nephrol. 20, 399-403 (2005).
76. Geary, D. F., Hodson, E. M. & Craig, J. C. Interventions for bone disease in children with chronic kidney disease. Cochrane Database Syst. Rev. Issue 1. Art. No.: CD008327. doi:10.1002/14651858.CD008327 (2010).
77. McKay, C. P & Portale, A. Emerging topics in pediatric bone and mineral disorders. Semin. Nephrol. 29, 370-378 (2009).
78. Schaefer, B. et al. Long-term control of parathyroid hormone and calcium-phosphate metabolism after parathyroidectomy in children with chronic kidney disease. Nephrol. Dial. Transplant. 25, 2590-2595 (2010).
79. VanDeVoorde, R. G. et al. Blood pressure control in pediatric hemodialysis: The Midwest Pediatric Nephrology Consortium Study. Pediatr. Nephrol. 22, 547-553 (2007).
80. Fadrowski, J. J. et al. Hemoglobin decline in children with chronic kidney disease: baseline results from the Chronic Kidney Disease in Children Prospective Cohort Study. Clin. J. Am. Soc. Nephrol. 3, 457-462 (2008).
81. Staples, A. O. et al. Anemia and risk of hospitalization in pediatric chronic kidney disease. Clin. J. Am. Soc. Nephrol. 4, 48-56 (2009).
82. Warady, B. A. & Ho, M. Morbidity and mortality in children with anemia at initiation of dialysis. Pediatr. Nephrol. 18, 1055-1062 (2003).
83. Mitsnefes M. M. Kartal J. Khoury P & Daniels, S. Adiponectin in children with chronic kidney disease: role of adiposity and kidney dysfunction. Clin. J. Am. Soc. Nephrol. 2, 46-50 (2007).
84. Flynn, J. T. et al. Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children Study. Hypertension 52, 631-637 (2008).
85. Saland, J. M. et al. Dyslipidemia in children with chronic kidney disease. Kidney Int. 78, 1154-1163 (2010).
86. Saland, J. M., Ginsberg, H. & Fisher, E. Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management. Curr. Opin. Pediatr. 14, 197-204 (2003).
87. Lai, H. L., Kartal, J. & Mitsnefes, M. M. Hyperinsulinemia in pediatric patients with chronic kidney disease: the role of tumor necrosis factor a. Pediatr. Nephrol. 22, 1751-1756 (2007).
88. Mitsnefes, M. M. et al. Abnormal carotid artery structure and function in children and adolescents with successful renal transplantation. Circulation 110, 97-101 (2004).
89. Goldstein, S. L. et al. Acute and chronic inflammation in pediatric patients receiving hemodialysis. J. Pediatr. 143, 653-657 (2003).
90. Menon, S., Valentini, R. P., Hidalgo, G., Peschansky, L. & Mattoo, T. K. Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease. Pediatr. Nephrol. 23, 1831-1836 (2008).
91. Rostand, S. G. & Drüeke, T. B. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int. 56, 383-392 (1999).
92. Merouani, A., Delvin, E. E., Genest, J. Jr, Rozen, R. & Lambert, M. Plasma homocysteine concentration changes after renal transplantation in children. Pediatr. Nephrol. 17, 520-523 (2002).
93. Merouani, A. et al. Plasma homocysteine concentration in children with chronic renal failure. Pediatr. Nephrol. 16, 805-811 (2001).
94. Feinstein, S. et al. Hyperhomocysteinemia in children on renal replacement therapy. Pediatr. Nephrol. 17, 515-519 (2002).
95. Omoloja, A. et al. Cigarette smoking and second-hand smoking exposure in adolescents with chronic kidney disease: a study from the Midwest Pediatric Nephrology Consortium. Nephrol. Dial. Transplant. 26, 908-913 (2011).